Published in Medical Letter on the CDC and FDA, August 6th, 2000
Written by a cardiologist at the University of Pittsburgh Medical Center, the report further states that the extension of trastuzumab use to patients with less invasive forms of breast cancer seems imprudent in view of untoward cardiac effects and should be reconsidered until additional information is available. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.